Physician profile

Todd K Schultz

Internal Medicine · Birmingham, AL

NPI 1679682678

$4,867.98

in general payments reported to CMS, 2019-2025

34 companies · $461 in 2025

The $461 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,426.17

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $877.24 2019-2025 Ozempic, Rybelsus
Pfizer INC. $600.17 2019-2024
Abbvie INC. $510.87 2021-2024
Janssen Pharmaceuticals, INC $381.66 2019-2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $288.84 2019-2025 Xifaxan
Amgen INC. $271.43 2019-2025 Repatha, Krystexxa
Abbott Laboratories $233.23 2021-2023 Freestyle Libre 2
Lilly USA, LLC $192.55 2019
Glaxosmithkline, LLC. $148.51 2022-2025 Shingrix, Arexvy, Trelegy Ellipta
Astellas Pharma US INC $148.25 2019-2025 Veozah, Myrbetriq
Dexcom, INC. $142.06 2023-2025 Dexcom G6 Transmitter
Merck Sharp & Dohme LLC $135.80 2019
Viiv Healthcare Company $123.91 2019
Amarin Pharma, INC. $94.12 2019-2021
Genentech USA, INC. $85.57 2019-2020
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Celgene Corporation $83.02 2025 Reblozyl
Novartis Pharmaceuticals Corporation $80.14 2021-2023
Allergan, INC. $76.97 2019-2020
Supernus Pharmaceuticals, INC. $56.06 2024 Qelbree
Kowa Pharmaceuticals America, INC. $50.56 2019
Gilead Sciences, INC. $35.70 2019
Sanofi-Aventis U.S. LLC $31.14 2019
Boehringer Ingelheim Pharmaceuticals, INC. $28.03 2019
Teva Pharmaceuticals USA, INC. $24.58 2019
Endogastric Solutions, INC $21.69 2024 Esophyx
Siemens Medical Solutions USA, INC. $20.82 2025 Immulite 1000 Immunoassay System
Sanofi Pasteur INC. $20.56 2019
Boston Scientific Corporation $20.21 2023
Astrazeneca Pharmaceuticals LP $14.56 2020
Pulmonx Corporation $14.48 2023 Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve
Alnylam Pharmaceuticals INC. $14.40 2022
Exact Sciences Corporation $14.00 2024 Cologuard Collection Kit
Takeda Pharmaceuticals U.S.A., INC. $13.46 2019
Currax Pharmaceuticals LLC $13.39 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Todd K Schultz

$4,867.98

in general payments reported 2019-2025

Years
2019-2025
Top company
Novo Nordisk INC
Context
The $461 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/166558/todd-k-schultz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.